SCM
FRTX

Sio Capital Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Sio Capital Management’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,221
Closed -$1.13M – 91
2019
Q2 		$1.13M Sell
4,221
-909
-18% -$305K 0.27% 59
2019
Q1 		$1.94M Hold
5,130
– – 0.52% 54
2018
Q4 		$1.91M Buy
5,130
+1,194
+30% +$468K 0.69% 49
2018
Q3 		$1.7M Buy
+3,936
New +$1.66M 0.58% 47

Other funds holding FRTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sio Capital Management's FRTX Position: Q3 2019 in Review

Sio Capital Management sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2019, closing a stake of 4,221 shares — an estimated $1.13M sold.

Sio Capital Management first reported a position in FRTX in Q3 2018 and held it in 4 quarters. The position peaked at $1.94M in Q1 2019. 17 funds tracked by Wall St. Rank hold FRTX as of Q3 2019.

  • Sio Capital Management reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Sio Capital Management sold 4,221 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $1.13M.
  • Sio Capital Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2018 and held it in 4 quarters.
  • Sio Capital Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $1.94M in Q1 2019.
  • 17 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Sio Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.